Share on LinkedInShare on LinkedIn

ARTICLE · 12 NOVEMBER 2021

U.S. Department Of Commerce Expands Controls On Biotech Software In Final Rule

On October 5, 2021, the U.S. Department of Commerce, Bureau of Industry and Security, published a final rule amending the Export Administration Regulations to include controls on certain biotechnology-related software, ...

United StatesGovernment, Public Sector

On October 5, 2021, the U.S. Department of Commerce, Bureau of Industry and Security (BIS), published a final rule amending the Export Administration Regulations (EAR) to include controls on certain biotechnology-related software, and technology used to develop that software, as emerging technology. Specifically, the controls apply to software designed for nucleic acid assemblers and synthesizers that are capable of designing and building functional genetic elements from digital sequence data.

BIS, consistent with its obligations under the Export Control Reform Act of 2018 (ECRA), previously identified this software as potential emerging technology essential to U.S. national security that could be misused for biological weapons purposes in a notice of proposed rulemaking on November 6, 2020. The final rule comes on the heels of the 42-country Australia Group's decision to add the software to its biological equipment control list, thereby aligning U.S. controls with

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from